Eric A Rose, MD Email Eric Rose
- PROFESSOR | Population Health Science and Policy
- PROFESSOR | Cardiovascular Surgery
- PROFESSOR | Surgery
- PROFESSOR | Medicine, Cardiology
- Cardiovascular Surgery
- Hospital Affiliation
- The Mount Sinai Hospital
World-renowned surgeon and scientist Eric A. Rose, MD, joined Mount Sinai as the Edmond A. Guggenheim, Professor and Chairman of the Department of Population Health Science & Policy, and Associate Director for Clinical Outcomes at Mount Sinai Heart.
In the Department of Population Health Science & Policy, Dr. Rose focuses on the study of long-term clinical outcomes. His work will be instrumental to translational research and clinical practices across the institution, which will enhance the Department's reputation as a state-of-the-art clinical research and outcomes center. At Mount Sinai Heart, Dr. Rose will concentrate on research that shapes patient care with an emphasis on clinical devices. Mount Sinai Heart continues to expand by capitalizing on innovative technologies that revolutionize the way medicine is practiced, and Dr. Rose's contributions in this area will help solidify Mount Sinai Heart as a leading research and clinical center for all cardiovascular conditions.
Dr. Rose is best known for making history in 1984 when he performed the first successful pediatric heart transplant. Since that landmark achievement, Dr. Rose has continued to study and improve cardiac surgical care in children and adults. His research has focused on the management of end-stage heart disease using artificial circulatory support "Mount Sinai has a long tradition of clinical excellence and has been a leader in translational research," says Dr. Rose. "I am delighted to join the Mount Sinai team." Dr. Rose also organized and led the National Institutes of Health (NIH)-funded Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial, which, in results published in 2001, conclusively demonstrated for the first time that long-term use of mechanical circulatory support devices prolongs and enhances life in non-transplantable, end-stage heart disease patients.
Dr. Rose's research has been continuously supported by the NIH. Over the course of his career, he has been involved in grants totaling more than $25 million in funding, including, most recently, a large National Heart, Lung, and Blood Institute project, the Human Biology of Long-Term Mechanical Circulatory Support. An innovative surgeon, Dr. Rose holds three patents, including one for fibrin surgical glue.
Dr. Rose is widely regarded as the architect behind the reorganization of the Department of Surgery at the Columbia Presbyterian Center of New York Presbyterian Hospital. The goal of that reorganization was to emphasize translational research. The Department's International Center for Health Outcomes and Innovation Research, also moving to Mount Sinai, has established an international reputation in health policy and clinical evaluative research.
After earning his medicaldegree from Columbia University, Dr. Rose completed residencies in surgery and thoracic surgery at what was then Presbyterian Hospital and then spent more than quarter of a century building his career at Columbia. At Columbia-Presbyterian Medical Center, Dr. Rose's Transplantation Service, Director of the Clinical Perfusion Service, Director of the Surgical Cardiac Intensive Care Unit, Chief of the Cardiothoracic Surgical Service, Valentine Mott/Johnson & Johnson Professor of Surgery, the Morris and Rose Milstein Professor of Surgery, and Associate Dean for Translational Research. Dr. Rose has also been Professor of Health Policy and Management at Columbia's Mailman School of Public Health.
Over the course of his career, Dr. Rose has authored or co-authored more than 300 peer-reviewed publications on topics such as cardiovascular surgery, ventricular assist devices, and cardiac transplantation, and he is the author of two books: Management of End-Stage Heart Disease and Second Opinion: The Columbia Presbyterian Guide to Surgery.
BA, Columbia College
MD, Columbia University, College of Physicians & Surgeons
MD, Columbia University College of Physicians & Surgeons
, Presbyterian Hospital
, Columbia University
, Presbyterian Hospital
, Presbyterian Hospital
Internship, General Surgery
Residency, General Surgery
Residency, Thoracic Surgery
Mark RJ, Gelijns AC, Stevenson LW, Sampat B, Aaronson KD, Renlund DG, Ascheim DD, Hong KN, Oz MC, Moskowitz AJ, Rose EA, Miller IW. REMATCH Investigators. The cost of medical management in advanced heart failure during the final two years of life. J Card Fail 2008 Oct; 14(8): 651-658.
Rose EA. A new continuous-flow LV assist device for patients with end-stage heart failure. Nat Clin Pract Cardiovasc Med 2008 Feb; 5(2): 80-81.
Chen JM, Naka Y, Rose EA. Progress versus precision: challenges in clinical trial design for left ventricular assist devices. Nat Clin Pract Cardiovasc Med 2006 Jul; 3(7): 346-347.
Parides MK, Moskowitz AJ, Ascheim DD, Rose EA, Gelijns AC. Progress versus precision: challenges in clinical trial design for left ventricular assist devices. Ann Thorac Surg 2006 Sep; 82(3): 1140-1146.
Biron A, Berkowitz RG, Bekhit EK, Rose EA. Ultrasound diagnosis of an internal carotid artery pseudoaneurysm in a young child. Int J Pediatr Otorhinolaryngol 2006 Nov; 70(11): 1975-1979.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Rose during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Service on Board of Directors: Service in a fiduciary capacity, such as an officer or director, for the following companies:
- ABIOMED, Inc.
- Mesoblast Ltd.
- SIGA Technologies Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.